These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6687846)

  • 1. Enzyme linked immunosorbent assay for Heymann's antigen as a contaminating minor component in nephritogenic glycopeptide, nephritogenoside.
    Natori Y; Shibata S
    Clin Exp Immunol; 1983 Mar; 51(3):595-9. PubMed ID: 6687846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephritogenic glycoprotein X. Correlation between the purity of nephritogenic glycopeptide, nephritogenoside, and morphological manifestation of glomerulonephritis.
    Shibata S; Natori Y
    Nephron; 1984; 37(2):85-93. PubMed ID: 6547212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephritogenic glycoprotein. XIII. Isolation and its immunochemical characterization of the antigenic substance of membranous glomerulonephritis induced by a single injection of crude nephritogenoside in homologous animals.
    Shibata S; Natori Y; Hayakawa I
    Nephron; 1989; 51(2):243-9. PubMed ID: 2644574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephritogenic glycoprotein. XI. Comparison of humoral immune responses in rats injected with nephritogenoside and those given Heymann antigen.
    Aotsuka S; Shibata S
    Nephron; 1987; 47(2):95-100. PubMed ID: 3696324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nephritogenic glycopeptide, nephritogenoside, isolated from rat glomerular basement membranes with other basement membrane components.
    Natori Y; Shibata S
    Connect Tissue Res; 1986; 15(4):245-55. PubMed ID: 2946548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of a 90-kD glycoprotein in Heymann's nephritis.
    Allegri L; Celendo MT; Ferrari C; Savazzi G; Ronco P; Verroust P
    Nephrol Dial Transplant; 1990; 5 Suppl 1():60-2. PubMed ID: 2129462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephritogenic glycopeptide (nephritogenoside): its existence in the urine of toxemia patients].
    Iioka H; Moriyama I; Amasaki M; Itoh K; Ichijo M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2279-86. PubMed ID: 3841141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugar composition of the nephritogenic glycopeptide, nephritogenoside, isolated from rat glomerular basement membrane.
    Shibata S; Saito H; Nakanishi H
    Biochim Biophys Acta; 1982 Feb; 714(3):456-64. PubMed ID: 6895855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephritogenic glycoprotein. XIV. A simple isolation method of nephritogenoside.
    Shibata S; Yokoyama M
    Nephron; 1990; 55(2):152-8. PubMed ID: 2362628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node cells from rats with Heymann's nephritis produce in vitro autoantibodies directed against purified renal tubular antigen.
    de Heer E; Daha MR; van Es LA
    Immunology; 1984 Aug; 52(4):743-52. PubMed ID: 6746001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The duality of Heymann nephritis antigen and immunogenoside--a minute quantity of a membranous nephritis-causing substance contained in somewhat crude nephritogenoside].
    Shibata S
    Arerugi; 1988 Jul; 37(7):397-403. PubMed ID: 3063233
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo treatment of Heymann's Nephritis using a cytotoxic protein-toxin conjugate.
    Misquith S; Surolia A
    FEBS Lett; 1995 Oct; 373(2):151-4. PubMed ID: 7589455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific uptake of Heymann's nephritic kidney eluate by rat kidney: studies in vivo and in isolated perfused kidneys.
    Neale TJ; Couser WG; Salant DJ; Lowenstein LM; Wilson CB
    Lab Invest; 1982 Apr; 46(4):450-3. PubMed ID: 7040800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cyclosporin A on the interstitial mononuclear cell infiltration and the induction of Heymann's nephritis.
    Grönhagen-Riska C; von Willebrand E; Tikkanen T; Honkanen E; Miettinen A; Holthöfer H; Törnroth T
    Clin Exp Immunol; 1990 Feb; 79(2):266-72. PubMed ID: 2311304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of nephritogenoside. A nephritogenic glycopeptide with alpha-N-glycosidic linkage.
    Shibata S; Takeda T; Natori Y
    J Biol Chem; 1988 Sep; 263(25):12483-5. PubMed ID: 3410849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephritogenic glycoprotein. VIII. Isolation and partial characterization of nephritogenic glycopeptide (nephritogenoside) from the terminal chorionic villus of human placenta.
    Shibata S; Iioka H; Natori Y; Moriyama I
    Connect Tissue Res; 1987; 16(2):153-62. PubMed ID: 2952452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clearance of pre-formed immune complexes in rats with Heymann's nephritis.
    O'Regan S
    Clin Exp Immunol; 1979 Sep; 37(3):432-5. PubMed ID: 315843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulatory antigen of Heymann nephritis. III. Presence of the 70-kD circulatory protein in the immune deposits of Heymann nephritis.
    Singh AK; Schwartz MM
    Clin Exp Immunol; 1991 Sep; 85(3):469-75. PubMed ID: 1893629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ciclosporin on active Heymann nephritis.
    Cattran DC
    Nephron; 1988; 48(2):142-8. PubMed ID: 3344054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunopathologic study of a 330-kD protein defined by monoclonal antibodies and reactive with anti-RTE alpha 5 antibodies and kidney eluates from active Heymann nephritis.
    Ronco P; Neale TJ; Wilson CB; Galceran M; Verroust P
    J Immunol; 1986 Jan; 136(1):125-30. PubMed ID: 2415612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.